PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-39

  1. 10 Posts.
    lightbulb Created with Sketch. 1
    Happy to be corrected, but it reads as though twice-weekly pain data is statistically significant, whilst the structural data is not as conclusive. In contrast, the once-weekly pain data is inconclusive, but shows stronger signals for the structural indicators. Is this correct?
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $104.9M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $161.3K 527.5K

Buyers (Bids)

No. Vol. Price($)
2 10756 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 62010 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.